Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted Therapy

Despite of remarkable progress made in the head and neck cancer (HNC) therapy, the survival rate of this metastatic disease remain low. Tailoring the appropriate therapy to patients is a major challenge and highlights the unmet need to have a good preclinical model that will predict clinical respons...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Oncol
Main Authors: Ghosh, Susmita, Prasad, Manu, Kundu, Kiran, Cohen, Limor, Yegodayev, Ksenia M., Zorea, Jonathan, Joshua, Ben-Zion, Lasry, Batel, Dimitstein, Orr, Bahat-Dinur, Anat, Mizrachi, Aviram, Lazar, Vladimir, Elkabets, Moshe, Porgador, Angel
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2019
Assuntos:
Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6350270/
https://ncbi.nlm.nih.gov/pubmed/30723707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00017
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares